Algernon Pharmaceuticals Announces Issuance of Patent for Ifenprodil for the Treatment...

Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to...

Delix Therapeutics Closes $30 Million Convertible Note Financing, Enters $10 Million...

PT331 – Julie Zukof & Dr. Michelle Weiner – Psychedelic Women,...

Stephen Bardin to Join atai Life Sciences as CFO Designate

Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental...

Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year...

GH Research Reports First Quarter 2022 Financial Results and Provides Business...

COMPASS Pathways presents largest ever study of psilocybin therapy, at American...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine...

Load more